These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18479986)

  • 1. The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice.
    Saibeni S; Virgilio T; D'Incà R; Spina L; Bortoli A; Paccagnella M; Peli M; Sablich R; Meucci G; Colombo E; Benedetti G; Girelli CM; Casella G; Grasso G; de Franchis R; Vecchi M
    Dig Liver Dis; 2008 Oct; 40(10):814-20. PubMed ID: 18479986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
    Wahed M; Louis-Auguste JR; Baxter LM; Limdi JK; McCartney SA; Lindsay JO; Bloom SL
    Aliment Pharmacol Ther; 2009 Sep; 30(6):614-20. PubMed ID: 19552632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease.
    Glas J; Török HP; Daczo J; Tonenchi L; Folwaczny M; Folwaczny C
    Eur J Med Res; 2005 Dec; 10(12):535-8. PubMed ID: 16356870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of methotrexate for treatment of inflammatory bowel disease in clinical practice.
    Saibeni S; Bollani S; Losco A; Michielan A; Sostegni R; Devani M; Lupinacci G; Pirola L; Cucino C; Meucci G; Basilisco G; D'Incà R; Bruno S
    Dig Liver Dis; 2012 Feb; 44(2):123-7. PubMed ID: 22051323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A report on efficacy and safety of azathioprine in a group of inflammatory bowel disease patients in northwest Greece.
    Christodoulou D; Katsanos K; Baltayannis G; Tzabouras N; Tsianos EV
    Hepatogastroenterology; 2003; 50(52):1021-4. PubMed ID: 12845970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease.
    Domènech E; Carrión S; Garcia-Planella E; Mañosa M; Gordillo J; Concepción M; Guarner C; Cabré E
    Inflamm Bowel Dis; 2011 Apr; 17(4):971-5. PubMed ID: 20824819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azathioprine dose escalation in inflammatory bowel disease.
    Rayner CK; Hart AL; Hayward CM; Emmanuel AV; Kamm MA
    Aliment Pharmacol Ther; 2004 Jul; 20(1):65-71. PubMed ID: 15225172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM; Iser JH; Gibson PR
    J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are patients with inflammatory bowel disease receiving optimal care?
    Reddy SI; Friedman S; Telford JJ; Strate L; Ookubo R; Banks PA
    Am J Gastroenterol; 2005 Jun; 100(6):1357-61. PubMed ID: 15929770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the need for azathioprine at first presentation in children with inflammatory bowel disease.
    Mossop H; Davies P; Murphy MS
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):123-9. PubMed ID: 18664861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Crohn disease in the Czech Republic in the years 1990 to 2001 and assessment of pediatric population with inflammatory bowel disease.
    Pozler O; Maly J; Bonova O; Dedek P; Frühauf P; Havlickova A; Janatova T; Jimramovsky F; Klimova L; Klusacek D; Kocourkova D; Kolek A; Kotalova R; Marx D; Nevoral J; Petro R; Petru O; Plasilova I; Seidl Z; Sekyrova I; Semendak N; Schreierova I; Stanek J; Sykora J; Sulakova A; Toukalkova L; Travnickova R; Volf V; Zahradnicek L; Zenisková I
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):186-9. PubMed ID: 16456413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study.
    Khan N; Abbas AM; Lichtenstein GR; Loftus EV; Bazzano LA
    Gastroenterology; 2013 Nov; 145(5):1007-1015.e3. PubMed ID: 23891975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
    Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
    Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center.
    Ott C; Girlich C; Klebl F; Plentz A; Iesalnieks I; Schölmerich J; Obermeier F
    Digestion; 2011; 84(3):187-92. PubMed ID: 21646782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Azathioprine in inflammatory bowel disease].
    Leite S; Ribeiro JM; Lima SC; Barroso S; Cotter J
    Acta Med Port; 2009; 22(1):33-40. PubMed ID: 19341591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.